Secondary Progressive Multiple Sclerosis (SPMS)
Also known as: Secondary Multiple Sclerosis, Progressive / Multiple Sclerosis, Secondary Progressive / Secondary-progressive Multiple Sclerosis / Secondary Progressive MS (SPMS) / Secondary Progressive MS / Secondary Progressive Multiple Sclerosis / Secondary progressive multiple sclerosis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00087 | Alemtuzumab | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. |
| DB00068 | Interferon beta-1b | A form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms. |
| DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
| DB00108 | Natalizumab | A monoclonal anti-integrin antibody which binds to the alpha 4 subunit of integrins to prevent migration of immune cells, and is used to treat Crohn's disease or multiple sclerosis. |
| DB09122 | Peginterferon beta-1a | An interferon beta used to treat relapsing forms of multiple sclerosis. |